In focus · trending topic

Hepatic Encephalopathy (HE)

2 stories · following the connections

Medical Marijuana, Inc. Portfolio Investment Company, Kannalife Sciences, Inc. Notified of DEA Clearance for Import of High-Purity, Pharmaceutical-Grade Cannabidiol (CBD)

By Nasdaq OMXMar 1, 2016, 2:00 PM UTC

Medical Marijuana, Inc. Portfolio Investment Company, Kannalife Sciences, Inc. Receives Publication Through American Chemical Society for KLS-13019, a Novel Cannabidiol-Derived Target Drug Candidate for Hepatic Encephalopathy

By Nasdaq OMXFeb 18, 2016, 2:00 PM UTC